2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Overview
Paper Summary
These guidelines provide recommendations for cardiovascular risk assessment, prevention, and management in cancer patients and survivors. They emphasize a personalized approach to care based on individual risk factors, cancer type, and cancer therapies.
Explain Like I'm Five
Scientists found that for people with cancer, it's important to also take good care of their heart. So, they made rules to help doctors check each person's heart and keep it healthy, depending on their cancer and treatment.
Possible Conflicts of Interest
The task force received financial support from the ESC without any involvement from the healthcare industry.
Identified Limitations
Rating Explanation
These guidelines provide an important framework for managing cardiovascular health in cancer patients. The recommendations are generally well-supported by expert consensus, though higher-quality evidence is needed in many areas. No conflicts of interest were identified beyond funding from the ESC.
Good to know
This is the Starter analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.
Explore Pro →